Your browser doesn't support javascript.
loading
HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.
Nelde, Annika; Walz, Juliane Sarah; Kowalewski, Daniel Johannes; Schuster, Heiko; Wolz, Olaf-Oliver; Peper, Janet Kerstin; Cardona Gloria, Yamel; Langerak, Anton W; Muggen, Alice F; Claus, Rainer; Bonzheim, Irina; Fend, Falko; Salih, Helmut Rainer; Kanz, Lothar; Rammensee, Hans-Georg; Stevanovic, Stefan; Weber, Alexander N R.
Afiliação
  • Nelde A; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
  • Walz JS; Department of Hematology and Oncology, University Hospital Tübingen , Tübingen, Germany.
  • Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
  • Schuster H; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
  • Wolz OO; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
  • Peper JK; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
  • Cardona Gloria Y; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
  • Langerak AW; Department of Immunology, Erasmus MC Rotterdam , Rotterdam, the Netherlands.
  • Muggen AF; Department of Immunology, Erasmus MC Rotterdam , Rotterdam, the Netherlands.
  • Claus R; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg , Freiburg, Germany.
  • Bonzheim I; Department of Pathology, University Hospital Tübingen , Tübingen, Germany.
  • Fend F; Department of Pathology, University Hospital Tübingen , Tübingen, Germany.
  • Salih HR; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany; Clinical Cooperation Unit Translational Immunology, German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.
  • Kanz L; Department of Hematology and Oncology, University Hospital Tübingen , Tübingen, Germany.
  • Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.
  • Stevanovic S; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.
  • Weber AN; Department of Immunology, Institute for Cell Biology, University of Tübingen , Tübingen, Germany.
Oncoimmunology ; 6(3): e1219825, 2017.
Article em En | MEDLINE | ID: mdl-28405493
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha